Ross L. Levine
Discovered the JAK2 mutation behind most myeloproliferative neoplasms and defined the genetics of clonal haematopoiesis.
Physician-scientist whose laboratory identified JAK2 V617F in myeloproliferative neoplasms and characterised TET2, ASXL1 and other mutations that drive clonal haematopoiesis and leukaemia evolution.
Pages like this
not linked directly; found by shared links- PersonBenjamin L. Ebert
Shares American Society of Hematology, Acute myeloid leukaemia.
- CollectionLeukemia & Lymphoma Society (LLS)
Shares American Society of Hematology, Acute myeloid leukaemia.
- IdeaShared splice-derived neoantigens as off-the-shelf vaccine targets
Shares Memorial Sloan Kettering Cancer Center, Acute myeloid leukaemia.
- IdeaWhich patients' blood clones will become leukaemia after treatment?
Shares Memorial Sloan Kettering Cancer Center, Acute myeloid leukaemia.
- InstitutionEuropean Hematology Association
Shares American Society of Hematology, Acute myeloid leukaemia.
- PathwayRNA splicing
Shares Memorial Sloan Kettering Cancer Center, Acute myeloid leukaemia.
- PathwayClonal haematopoiesis (CHIP)
Shares Memorial Sloan Kettering Cancer Center, Acute myeloid leukaemia.